Tomas R. Vazquez-Rodriguez

TL;DR: No significant association between the VEGFA rs2010963 and the rs1570360 polymorphisms with clinically evident CV disease was found in this series of patients with RA, and this was also the case when the authors examined the contribution of these polymorphisms to the development of subclinical atherosclerosis.

TL;DR: A potential implication of the CD40 rs1883832 C/T polymorphism in susceptibility to visual ischemic manifestations in individuals with biopsy-proven giant cell arteritis is suggested.

TL;DR: LEP rs2167270 polymorphism does not seem to be a genetic risk factor for disease susceptibility or clinically evident CV disease and subclinical atherosclerosis in patients with RA.

TL;DR: In this paper, an observational, retrospective study of 41 polyarticular JIA patients treated with anti-TNF therapy was conducted, where the authors assessed clinical remission, flare, ACR improvement, improvement of DAS-28, and JADAS.

TL;DR: The results do not show that MIF-173 gene polymorphism may infer a direct risk for disease susceptibility or CV disease in patients with rheumatoid arthritis.